(1-Methyl-1H-benzo[d]imidazol-5-yl)methanol, 95.0%, 250mg

N-(3-cyanophenyl)-N-(4-methoxyphenyl)amine, 97.0%, 250mg

3-(Dimethylamino)pyrrolidine>98.0%(GC)(T)25g

4-(1,3-Dimethyl-2,3-dihydro-1H-benzimidazol-2-yl)-N,N-dimethylaniline>95.0%(T)1g

(R)-3-((tert-Butoxycarbonyl)amino)-2-phenylpropanoic acid, 95.0%, 100mg

D-Glucopyranose, 2-(acetylamino)-2-deoxy-, 1,3,4,6-tetraacetate, 95%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((bis(methylamino)methylene)amino)pentanoic acid, 97%, 1g

tert-Butyl 2-(trifluoromethyl)acrylate, 97%, 1g

Soluzione di formaldeide al 30 %, a basso contenuto di metanolo, 30 l

Ethyl 4-fluoro-1H-indole-7-carboxylate, 97%, 100mg

N,N,N',N'',N''-Pentakis(2-hydroxypropyl)diethylenetriamine>95.0%(T)25g

Methyl 5-chlorobenzo[b]thiophene-2-carboxylate, 95.0%, 1g

Ethyl 7-methylpyrazolo[1,5-a]pyridine-3-carboxylate, 95.0%, 1g